Targeting glycolysis can help lower neutrophil extracellular trap formation in antiphospholipid syndrome. Neutrophils are an important type of white blood cell that help your immune system fight ...

Antiphospholipid syndrome (APS) is an autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL), which significantly increase the risk of thrombosis and adverse ...

SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest obstacles in managing antiphospholipid syndrome, according to a speaker at the 2024 ...

APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as ...

The primary manifestation of the antiphospholipid antibody syndrome (APS) is thrombosis, which forms the core of the classification criteria for this syndrome. However, multiple other noncriteria ...

Credit: Getty Images More than 20% of ischemic strokes in patients aged 45 years or younger are associated with Antiphospholipid syndrome, but its exact etiology and pathophysiology are not yet fully ...

The antiphospholipid antibody syndrome is rare. Accordingly, it is remarkable that Crowther and his 19 partners [1] could devise a clinical trial involving 114 patients. The investigators discovered ...

A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.

“There are a lot of unanswered questions about how APS affects pediatric patients since evidence to date has been very limited,” said Jheel Pandya, MD, a pediatric rheumatology fellow at HSS and lead ...

Please provide your email address to receive an email when new articles are posted on . This is the first classification criteria revision for antiphospholipid syndrome since 2006. The new guidelines ...